Alliance Pharmaceuticals Limited
Jerry Coughlin is a seasoned professional in innovation project management and new product development, currently serving as Senior Innovation Project Manager at Alliance Pharmaceuticals Limited since November 2018. Previously, Jerry held various roles at RB from January 2010 to October 2018, including NPD Manager for Hygiene + Home, where notable achievements included serving as a Subject Matter Expert to streamline the global change control process, significantly reducing project lead times. Other key positions included NPI & Data Manager and Category Activity Manager for Durex, where Jerry successfully managed numerous new product developments and enhancements. Jerry holds a Bachelor's Degree in Broadcasting from The University of Salford and an HND in New Media & Music Management from City College, Manchester.
This person is not in any offices
Alliance Pharmaceuticals Limited
1 followers
We are Alliance Pharma plc, an international healthcare group. Our purpose is to improve the lives of consumers and patients, through making available a range of clinically valuable healthcare products. Headquartered in the UK, we employ more than 250 people based in locations across Europe, North America, and the Asia Pacific region. Our core focus is on the marketing of Consumer Healthcare brands. We also have a smaller Prescription Medicines business, which operates alongside this. In total, we hold marketing rights to around 80 brands, with our revenues being generated from a mix of direct, distributor and e-commerce sales. With annual revenues in excess of £160m, good margins and strong cash generation, we’re financially successful and have a strong appetite for growth. Outsourcing all of our manufacturing and logistics activities allows us to remain asset-light and to focus on leveraging the operating platform we’ve built across EMEA, AMER and APAC, in order to maximise the value and reach of our brands. For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com Adverse Event Reporting Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Pharmacovigilance at Alliance Pharmaceuticals (tel: 01249 466966, email: pharmacovigilance@alliancepharma.co.uk)